Literature DB >> 12611657

Development and application of a robust speciation method for determination of six arsenic compounds present in human urine.

Lisa S Milstein1, Amal Essader, Edo D Pellizzari, Reshan A Fernando, James H Raymer, Keith E Levine, Olujide Akinbo.   

Abstract

Six arsenic species [arsenate, arsenite, arsenocholine, arsenobetaine, monomethyl arsonic acid, and dimethyl arsinic acid] present in human urine were determined using ion-exchange chromatography combined with inductively coupled plasma mass spectrometry (IC-ICP-MS). Baseline separation was achieved for all six species as well as for the internal standard (potassium hexahydroxy antimonate V) in a single chromatographic run of less than 30 min, using an ammonium carbonate buffer gradient (between 10 and 50 mM) at ambient temperature, in conjunction with cation- and anion-exchange columns in series. The performance of the method was evaluated with respect to linearity, precision, accuracy, and detection limits. This method was applied to determine the concentration of these six arsenic species in human urine samples (n = 251) collected from a population-based exposure assessment survey. Method precision was demonstrated by the analysis of duplicate samples that were prepared over a 2-year analysis period. Total arsenic was also determined for the urine samples using flow injection analysis coupled to ICP-MS. The summed concentration of the arsenic species was compared with the measured arsenic total to demonstrate mass balance.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12611657      PMCID: PMC1241385          DOI: 10.1289/ehp.5525

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  8 in total

1.  Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India.

Authors:  B K Mandal; Y Ogra; K T Suzuki
Journal:  Chem Res Toxicol       Date:  2001-04       Impact factor: 3.739

2.  Arsenic speciation in human urine reference materials using high-performance liquid chromatography with inductively coupled plasma mass spectrometric detection.

Authors:  J Zheng; W Kosmus; F Pichler-Semmelrock; M Köck
Journal:  J Trace Elem Med Biol       Date:  1999-11       Impact factor: 3.849

3.  Design strategy for assessing multi-pathway exposure for children: the Minnesota Children's Pesticide Exposure Study (MNCPES).

Authors:  J J Quackenboss; E D Pellizzari; P Shubat; R W Whitmore; J L Adgate; K W Thomas; N C Freeman; C Stroebel; P J Lioy; A C Clayton; K Sexton
Journal:  J Expo Anal Environ Epidemiol       Date:  2000 Mar-Apr

4.  Speciation of key arsenic metabolic intermediates in human urine.

Authors:  X C Le; X Lu; M Ma; W R Cullen; H V Aposhian; B Zheng
Journal:  Anal Chem       Date:  2000-11-01       Impact factor: 6.986

5.  Automated, continuous, and dynamic speciation of urinary arsenic in the bladder of living organisms using microdialysis sampling coupled on-line with high performance liquid chromatography and hydride generation atomic absorption spectrometry.

Authors:  Wei-Chang Tseng; Mo-Hsiung Yang; Tyen-Po Chen; Yeou-Lih Huang
Journal:  Analyst       Date:  2002-04       Impact factor: 4.616

6.  Population-based exposure measurements in EPA region 5: a phase I field study in support of the National Human Exposure Assessment Survey.

Authors:  E Pellizzari; P Lioy; J Quackenboss; R Whitmore; A Clayton; N Freeman; J Waldman; K Thomas; C Rodes; T Wilcosky
Journal:  J Expo Anal Environ Epidemiol       Date:  1995 Jul-Sep

7.  Selection of a suitable mobile phase for the speciation of four arsenic compounds in drinking water samples using ion-exchange chromatography coupled to inductively coupled plasma mass spectrometry.

Authors:  Lisa S Milstein; Amal Essader; Edo D Pellizzari; Reshan A Fernando; Olujide Akinbo
Journal:  Environ Int       Date:  2002-09       Impact factor: 9.621

8.  Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine.

Authors:  X C Le; M Ma; W R Cullen; H V Aposhian; X Lu; B Zheng
Journal:  Environ Health Perspect       Date:  2000-11       Impact factor: 9.031

  8 in total
  6 in total

1.  Environmental arsenic exposure and serum matrix metalloproteinase-9.

Authors:  Jefferey L Burgess; Margaret Kurzius-Spencer; Mary Kay O'Rourke; Sally R Littau; Jason Roberge; Maria Mercedes Meza-Montenegro; Luis Enrique Gutiérrez-Millán; Robin B Harris
Journal:  J Expo Sci Environ Epidemiol       Date:  2012-12-12       Impact factor: 5.563

2.  DNA methylation of extracellular matrix remodeling genes in children exposed to arsenic.

Authors:  Tania Gonzalez-Cortes; Rogelio Recio-Vega; Robert Clark Lantz; Binh T Chau
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-01       Impact factor: 4.219

3.  Methylation of inorganic arsenic by murine fetal tissue explants.

Authors:  Derrick Broka; Eric Ditzel; Stephanie Quach; Todd D Camenisch
Journal:  Drug Chem Toxicol       Date:  2015-10-07       Impact factor: 3.356

4.  Assessing the measurement precision of various arsenic forms and arsenic exposure in the National Human Exposure Assessment Survey (NHEXAS).

Authors:  Edo D Pellizzari; C Andrew Clayton
Journal:  Environ Health Perspect       Date:  2006-02       Impact factor: 9.031

5.  Differential susceptibility of human peripheral blood T cells to suppression by environmental levels of sodium arsenite and monomethylarsonous acid.

Authors:  Scott W Burchiel; Fredine T Lauer; Ellen J Beswick; A Jay Gandolfi; Faruque Parvez; Ke Jian Liu; Laurie G Hudson
Journal:  PLoS One       Date:  2014-10-01       Impact factor: 3.240

6.  Association of Children's Urinary CC16 Levels with Arsenic Concentrations in Multiple Environmental Media.

Authors:  Paloma I Beamer; Walter T Klimecki; Miranda Loh; Yoshira Ornelas Van Horne; Anastasia J Sugeng; Nathan Lothrop; Dean Billheimer; Stefano Guerra; Robert Clark Lantz; Robert A Canales; Fernando D Martinez
Journal:  Int J Environ Res Public Health       Date:  2016-05-23       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.